BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Allogeneic hematopoietic stem cell transplantation is considered to be a curative approach towards several diseases such as chronic myeloid leukemia (CML), since it can lead to molecular remission of the BCR-ABL gene.1–3 Nevertheless, the high costs relating to this procedure and a lack of hospital beds may impair its utilization in many institutions.